Director, Business Development - Drug Discovery - Remote

Cambridge Permanent USD130,000 - USD150,000
  • Global CRO seeing rapid growth on top of solid existing international presence
  • Great opportunity for a small molecule scientist seeking a transition into BD

About Our Client

Our client is a global R&D service provider with a broad spectrum of research, development and manufacturing service capabilities across the complete drug discovery, development, and manufacturing cycle.

Job Description

MPI does not discriminate on the basis of race, color, religion, sex, sexual orientation, gender identity or expression, national origin, age, disability, veteran status, marital status, or based on an individual's status in any group or class protected by applicable federal, state or local law. MPI encourages applications from minorities, women, the disabled, protected veterans and all other qualified applicants.

Description

  • Identify and qualify customers in assigned territory
  • Maintain ongoing contacts with prospective and current customers to increase business growth
  • Conduct and report industry related market research
  • Communicate customer feedback to internal teams

The Successful Applicant

  • Advanced degree in Biochemistry, Biology, or related discipline
  • Knowledge of the drug discovery and development market
  • Scientist seeking transition into commercial function
  • Experience in Sales/Business Development a plus, but not required
  • Experience selling CDMO/CRO services or pharmaceutical assets a plus, but not required
  • Authorization to work in the US without restriction or sponsorship

What's on Offer

  • Base salary: $130k - $150k (dependent on experience)
  • Variable: 20% performance bonus
  • Benefits: Competitive
  • Location: Remote
Contact
Payum Noshiravan
Quote job ref
JN-022022-5269079

Job summary

Sector
Sales
Sub Sector
New Business Development
Industry
Healthcare / Pharmaceutical
Location
Cambridge
Contract Type
Permanent
Consultant name
Payum Noshiravan
Job Reference
JN-022022-5269079